You can start NuvaRing on any day—but the latest day you can begin on is the day after taking your last “inactive” (hormone-free) pill. If you have been using your birth control consistently and correctly, you should not need an extra birth control method when you transition.
When and how you start using NuvaRing will depend on your doctor's recommendation and your current birth control method. It is important to talk with your doctor to make sure you are not pregnant before starting NuvaRing.
How to begin using NuvaRing
Below are some basic guidelines for starting NuvaRing. As with any birth control, you should talk to your doctor and consult the Patient Information for more details.
See for yourself how to get started.
If you are switching to NuvaRing from:
The pill (combination progestin and estrogen)
A patch (combination progestin and estrogen)
You can start NuvaRing on any day—but the latest day you can begin on is the one following your usual patch-free week. If you have been using your hormonal birth control consistently and correctly, you should not need an extra birth control method when you transition.
A progestin-only method (mini-pill, implant or injection) or from a progestin-releasing intrauterine
You may switch on any day from the mini-pill. You should switch from an implant or the IUD on the day of its removal and from an injectible on the day when the next injection would be due. In all of these cases you should use an additional method of birth control, such as a male condom or spermicide, for the first seven days of ring use.
If you are starting NuvaRing after:
If you haven’t used a hormonal birth control method or have been using only condoms, a diaphragm,
or other barrier method of birth control in the past month
Insert NuvaRing on the first day of your cycle, (i.e., the first day of menstrual bleeding). NuvaRing will work immediately, it is not necessary to use an additional contraceptive method. You may also start on Day 2 to 5 of your cycle, but in this case make sure you use an extra method of birth control (barrier method), such as male condoms or spermicide for the first seven days of NuvaRing use in the first cycle.
If you have delivered a baby or had a second-trimester abortion
If you choose not to breastfeed, you may start NuvaRing 4 weeks postpartum.
Women who are breastfeeding should not use NuvaRing until the child is weaned.
Until then choose another form of birth control.
When NuvaRing is used postpartum or post-abortion, the increased risk of thromboembolism (a blood clot) must be considered. For more information, see the Patient Information and consult your doctor. If you begin using NuvaRing postpartum you will need to use an additional method of birth control (such as condoms or spermicide) for the first 7 days. If you have not yet had a period, the possibility of ovulation and conception occurring prior to starting NuvaRing should be considered.
If you had a first-trimester abortion or miscarriage
If you start using NuvaRing within 5 days after a first-trimester abortion or miscarriage,
you do not need to use an extra birth control method.
If you do not start NuvaRing within 5 days after a first-trimester abortion or miscarriage, begin using NuvaRing at the time of your next period. Insert NuvaRing on the first day of your cycle, (i.e., the first day of menstrual bleeding). NuvaRing will work immediately, it is not necessary to use an additional contraceptive method. You may also start on Day 2 to 5 of your cycle, but in this case make sure you use an extra method of birth control (barrier method), such as male condoms or spermicide for the first 7 days of NuvaRing use in the first cycle.
Prescription NuvaRing is a flexible vaginal ring approved for the prevention of pregnancy in women.
Important Safety Information
Cigarette smoking increases the risk of serious cardiovascular side effects when you use combination oral contraceptives. This risk increases even more if you are over age 35 and if you smoke 15 or more cigarettes a day. Women who use combination hormonal contraceptives, including NuvaRing, are strongly advised not to smoke.
- The use of combination oral contraceptives is associated with increased risks of several serious side effects, including blood clots, stroke, or heart attack. NuvaRing is not for women with a history of these conditions. The risk of getting blood clots may be greater with the type of progestin in NuvaRing than with some other progestins in certain low-dose birth control pills. It is unknown if the risk of blood clots is different with NuvaRing use than with the use of certain birth control pills.
- NuvaRing is not for women with certain cancers or those who may be pregnant.
- NuvaRing does not protect against HIV infection and other sexually transmitted diseases.
- The most common side effects reported by NuvaRing users are: vaginal infections and irritation, vaginal secretion, headache, weight gain, and nausea.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please read the Patient Information for NuvaRing, including the information about the increased risk of serious cardiovascular side effects, especially in women who smoke, and discuss it with your doctor. The physician Prescribing Information is also available.
Back to top